Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Central Admixture Pharmacy Services, Inc.
483
•Central Admixture Pharmacy Services, Inc.•March 7, 2013

Central Admixture Pharmacy Services, Inc. – FDA 483, Mar 7, 2013

Record Details

During an FDA inspection conducted from March 4-7, 2013, Central Admixture Pharmacy Services, Inc., a producer of sterile drug products in Homewood, AL, received a Form FDA 483 detailing significant observations of non-compliance with Current Good Manufacturing Practices (cGMP).

The primary issues centered on critical quality control and aseptic processing failures. The firm was observed distributing sterile drug products, including Cardioplegia and Oxytocin, without ensuring complete sterility, endotoxin, identity, and strength testing *prior* to release. Notably, some Cardioplegia batches that later failed sterility tests had already been distributed.

Further concerns involved deficient environmental controls, such as the absence of continuous monitoring for positive pressure differentials in clean rooms and inadequate environmental monitoring within laminar flow hoods during aseptic operations. Personnel were observed with exposed facial hair and skin, compromising sterility. Additionally, there were no written procedures for sporicidal cleaning agents in critical areas, and key process validations like bacterial retention testing and positive controls in media fills were lacking.

Other significant observations included a lack of a written stability program for sterile products, insufficient scope in discrepancy investigations, failure to retain reserve samples for drug lots, and non-adherence to complaint handling procedures. The company is expected to implement prompt and comprehensive corrective actions to address these serious deficiencies and achieve full regulatory compliance, ensuring the safety and quality of their sterile drug products.

Company
Central Admixture Pharmacy Services, Inc.
Inspection date
March 7, 2013
Product type
Drugs
Office
New Orleans District Office
People
  • Marie A. Fadden ( Investigator, Consumer Safety Officer)
  • Paul C. Mouris (GDUFA Supervisory Investigator)
View Company Profile

ID · 772ab7ef-552c-4bd9-951d-11ec87117fa1

Violation Codes2
21 CFR 21021 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Central Admixture Pharmacy Services, Inc.
  • 483 - 2007-01-19January 19, 2007

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Central Admixture Pharmacy Services, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.